Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosageChun‐Jen Liu, Pei‐Jer Chen, Stanley Shi-Chung Chang et al.|Journal of Hepatology|2009Cited by 157
Survival rate in nasopharyngeal carcinoma improved by high caseload volume: a nationwide population-based study in TaiwanChing-Chih Lee, Shih‐Kai Hung, Wen‐Yen Chiou et al.|Radiation Oncology|2011Cited by 36
The Impact of Influenza Vaccinations on the Adverse Effects and Hospitalization Rate in the Elderly: A National Based Study in an Asian CountryTsung-Yu Ho, Ching-Chih Lee, Kuang-Yung Huang et al.|PLoS ONE|2012Cited by 16